2017 Projects & Working Groups

CommNETS is funded by Sponsorship provided by Ipsen Australia and an Education Grant provided by Ipsen Canada

Appendiceal NET – Are we overtreating?
Financial Toxicity of NET.
MEN Database.
Recommendations for optimal clinical trial design in (advanced) NETs: consensus recommendations for trial endpoints from the CommNETS collaboration.
Making pNETs immunogenic.
NET classification by cell type
PRRT and QOL.
Design and creation of an optimal shared care model for NETS patients in the community.
Systematic review of surgical trials in NET.
Pituitary dysfunction after PRRT
Identifying outcomes that are meaningful to patients
Paediatrics and AYA NETS

For full details click here.

Changing outcomes for people with GIgastro-intestinal cancer